Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis

Blood (2010) 116 (21): 987.

https://doi.org/10.1182/blood.V116.21.987.987

Published: 2010

Journal Articles

Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease

Blood (2010) 116 (21): 863.

https://doi.org/10.1182/blood.V116.21.863.863

Published: 2010

Journal Articles

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Morie Abraham Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3554.

https://doi.org/10.1182/blood.V116.21.3554.3554

Published: 2010

Journal Articles

Acute Renal Failure Is a Common Presentation of Engraftment Syndrome In Light Chain Amyloidosis (AL) Patients After Autologous Stem Cell transplantation.

Maria V Irazabal, MD, Aflonso Eirin, MD, Morie Abraham A. Gertz, MD, Angela Dispenzieri, MD, Shaji Kumar, MD, Francis Buadi, MD, Martha Lacy, MD, Suzanne R. Hayman, MD, David Dingli, MD, PhD, William J Hogan, MBBCh, Nelson Leung, MD

Blood (2010) 116 (21): 3468.

https://doi.org/10.1182/blood.V116.21.3468.3468

Published: 2010

Journal Articles

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Morie Abraham Gertz, MD, Dennis Gastineau, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Shaji Kumar, MD, David Dingli, M.D., Ph.D., Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Francis Buadi, MD

Blood (2010) 116 (21): 3469.

https://doi.org/10.1182/blood.V116.21.3469.3469

Published: 2010

Journal Articles

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Morie Abraham A. Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Shaji Kumar, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Stephen M. Ansell, MD, PhD, Dennis Gastineau, MD, David James Inwards, MD, Patrick B Johnston, MD, PhD, Mark R. Litzow, MD, Ivana Micallef, MD, Luis Porrata, MD, Nelson Leung, MD, Robert Wolf, PharmD, RPh, William J Hogan, MBBCh, Suzanne R. Hayman, MD

Blood (2010) 116 (21): 3557.

https://doi.org/10.1182/blood.V116.21.3557.3557

Published: 2010

Journal Articles

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Nelson Leung, MD, Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., William J Hogan, MBBCh, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2010) 116 (21): 3572.

https://doi.org/10.1182/blood.V116.21.3572.3572

Published: 2010

Journal Articles

Unraveling Early Mortality In Patients with AL Amyloidosis

Cheng E. Chee, MD, Vincent Rajkumar, PhD, Morie Gertz, Martha Lacy, MD, Steven Zeldenrust, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MB, CHB, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 4990.

https://doi.org/10.1182/blood.V116.21.4990.4990

Published: 2010

Journal Articles

Pre-Stem Cell Transplant Induction Therapy Does Not Affect Post-Transplant Survival In Light Chain (AL) Amyloidosis

Sumit Madan, MD, Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Francis Buadi, MD, Suzanne R. Hayman, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Morie Gertz, MD

Blood (2010) 116 (21): 370.

https://doi.org/10.1182/blood.V116.21.370.370

Published: 2010

Journal Articles

Collection of Stem Cell Early In the Disease Course of Multiple Myeloma Is Associated with Early Engraftment.

Francis Buadi, MD, Angela Dispenzieri, MD, Shaji Kumar, MD, Martha Lacy, MD, David Dingli, M.D., Ph.D., Suzanne R. Hayman, MD, William J Hogan, MBBCh, Nelson Leung, MD, Dennis Gastineau, MD, Morie Abraham A Gertz, MD

Blood (2010) 116 (21): 4518.

https://doi.org/10.1182/blood.V116.21.4518.4518

Published: 2010

Journal Articles

Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma

Sumit Madan, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Morie Gertz, MD, Francis Buadi, MD, Suzanne R. Hayman, MD, Kristen Detweiler-Short, David Dingli, M.D., Ph.D., Steven Zeldenrust, MD, John Lust, MD, PhD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 1964.

https://doi.org/10.1182/blood.V116.21.1964.1964

Published: 2010

Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD

Blood (2010) 116 (21): 1965.

https://doi.org/10.1182/blood.V116.21.1965.1965

Published: 2010

Journal Articles

Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score

Shaji Kumar, MD, Morie Gertz, MD, Martha Lacy, MD, David Dingli, MD, PhD, Suzanne R. Hayman, MD, Francis Buadi, MD, Kristen Detweiler-Short, Steven Zeldenrust, MD, Nelson Leung, MD, Philip R. Greipp, MD, John Lust, MD, PhD, Stephen Russell, MD, PhD, Robert Kyle, MD, Vincent Rajkumar, Angela Dispenzieri, MD

Blood (2010) 116 (21): 1892.

https://doi.org/10.1182/blood.V116.21.1892.1892

Published: 2010

Journal Articles

Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis

Cheng E. Chee, MD, S. Vincent Rajkumar, MD, Morie Abraham A Gertz, MD, Martha Lacy, MD, Steven Zeldenrust, MD, Shaji Kumar, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, Stephen Russell, MD, PhD, Robert Kyle, MD, Philip R. Greipp, MD, Angela Dispenzieri, M.D.

Blood (2010) 116 (21): 1893.

https://doi.org/10.1182/blood.V116.21.1893.1893

Published: 2010

Journal Articles

Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function

Shaji Kumar, MD, Angela Dispenzieri, M.D., Martha Lacy, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Kristen Detweiler-Short, RN, John Lust, Steven Zeldenrust, MD, Stephen Russell, MD, PhD, Philip R. Greipp, MD, Robert Kyle, MD, Morie Gertz, MD, Vincent Rajkumar

Blood (2010) 116 (21): 2970.

https://doi.org/10.1182/blood.V116.21.2970.2970

Published: 2010

Journal Articles

Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease

Kristen Detweiler Short, RN, CNP, S. Vincent Rajkumar, MD, Francis Buadi, MD, Dirk Larson, Suzanne R. Hayman, MD, Angela Dispenzieri, MD, Morie Abraham A Gertz, MD, Shaji Kumar, MD, Joseph R. Mikhael, MD, Vivek Roy, Robert Kyle, MD, Martha Lacy, MD

Blood (2010) 116 (21): 3047.

https://doi.org/10.1182/blood.V116.21.3047.3047

Published: 2010

Journal Articles

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Shirshendu Sinha, MBBS, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, MD, Ph.D., Ivana Micallef, MD, William Hogan, MBBCh, Dennis Gastineau, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 2253.

https://doi.org/10.1182/blood.V116.21.2253.2253

Published: 2010

Journal Articles

Five-Year Follow-up of Randomized, Phase II Trial of Idiotype-Pulsed Dendritic Cell Vaccine with Adjuvant Cytokines In Plateau Phase and Post-Transplant Multiple Myeloma

Yi Lin, MDPhD, Morie Gertz, MD, Sumithra Mandrekar, PhD, Kristina Laumann, Angela Dispenzieri, MD, Suzanne R. Hayman, MD, Francis Buadi, MD, David Dingli, M.D., Ph.D., Douglas Padley, Dennis Gastineau, MD, Shaji Kumar, MD, Vincent Rajkumar, Martha Lacy, MD

Blood (2010) 116 (21): 1958.

https://doi.org/10.1182/blood.V116.21.1958.1958

Published: 2010

Journal Articles

Long Term Follow-up of Patients with Immunoglobulin Light Chain Amyloidosis Treated with Lenalidomide and Dexamethasone.

Angela Dispenzieri, Martha Lacy, MD, Stephen R. Zeldenrust, Suzanne R. Hayman, MD, Shaji K. Kumar, John A. Lust, MD, PhD, Jake Allred, S. Vincent Rajkumar, Philip R. Greipp, MD, Kristina Laumann, Stephen Russell, Francis Buadi, Thomas E Witzig, Morie A Gertz

Blood (2008) 112 (11): 1737.

https://doi.org/10.1182/blood.V112.11.1737.1737

Published: 2008

Journal Articles

Perioperative Outcome of Patients with Acquired Factor X Deficiency Associated with AL Amyloidosis: The Mayo Clinic Experience.

Carrie Thompson, MD, Robert Kyle, MD, Morie Gertz, MD, Martha Lacy, MD, John A. Heit, MD, Rajiv Pruthi, MD, Animesh D. Pardanani, MD

Blood (2007) 110 (11): 3965.

https://doi.org/10.1182/blood.V110.11.3965.3965

Published: 2007

NARROW

A Phase-2 Study of Pomalidomide and Dexamethasone In Previously-Treated Light-Chain (AL) Amyloidosis

Pomalidomide Plus Low-Dose Dexamethasone In Myeloma Refractory to Both Bortezomib and Lenalidomide: Comparison of Two Dosing Strategies In Dual-Refractory Disease

Trend towards Improved Day 100 and 2-Year Survival After SCT for AL Amyloidosis: Outcomes Before and After 2006

Acute Renal Failure Is a Common Presentation of Engraftment Syndrome In Light Chain Amyloidosis (AL) Patients After Autologous Stem Cell transplantation.

Stem Cell Transplant without Growth Factor In Multiple Myeloma: Engraftment Kinetics, Bacteremia, and Hospitalization.

Transplantation for Immunoglobulin Light Chain Amyloidosis. A Statistical Analysis of Factors Predicitng Outcome In Over 400 Patients

Comparison of Troponin T and N-Terminal-Pro-Brain Natriuretic Peptides In Two Models of Treatment Related Mortality In AL Amyloidosis Patients Following Autologous Stem Cell Transplantation

Unraveling Early Mortality In Patients with AL Amyloidosis

Pre-Stem Cell Transplant Induction Therapy Does Not Affect Post-Transplant Survival In Light Chain (AL) Amyloidosis

Collection of Stem Cell Early In the Disease Course of Multiple Myeloma Is Associated with Early Engraftment.

Efficacy of Retreatment with Immunomodulatory Compounds In Patients Receiving Initial Therapy for Newly Diagnosed Multiple Myeloma

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Recent Improvements In Survival In Light Chain Amyloidosis and the Importance of An Early Mortality Risk Score

Higher Plasma Cell Burden Predicts for Early Death In Patients with AL Amyloidosis

Improvement In Renal Function In Newly Diagnosed Myeloma Improves Survival, but Still Remains Inferior to Those with Normal Renal Function

Increased Incidence of Extramedullary Plasmacytomas In Patients with Multiple Myeloma In the Era of Novel Therapy and Effect of Pomalidomide on Extramedullary Disease

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Five-Year Follow-up of Randomized, Phase II Trial of Idiotype-Pulsed Dendritic Cell Vaccine with Adjuvant Cytokines In Plateau Phase and Post-Transplant Multiple Myeloma

Long Term Follow-up of Patients with Immunoglobulin Light Chain Amyloidosis Treated with Lenalidomide and Dexamethasone.

Perioperative Outcome of Patients with Acquired Factor X Deficiency Associated with AL Amyloidosis: The Mayo Clinic Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only